Should serotonin-noradrenaline reuptake inhibitors be considered the most effective neuromodulators for irritable bowel syndrome?

Gut · Published 2026-07-22 · DOI 10.1136/gutjnl-2026-340002

Authors (3)

Christian Von Muhlenbrock, Tim Vanuytsel, Jan Tack

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Muhlenbrock, C., Vanuytsel, T., Tack, J. (2026). Should serotonin-noradrenaline reuptake inhibitors be considered the most effective neuromodulators for irritable bowel syndrome?. Gut. https://doi.org/10.1136/gutjnl-2026-340002

Related articles

• Letter in reply: should SNRIs be considered the most effective neuromodulators for IBS? · Gut · 2026 · Cites or is cited by this article · Same journal
• A patient-driven agenda for liver cirrhosis research · Gut · 2026 · Same journal
• International consensus on intestinal epithelial barrier assessment and therapeutic effects in inflammatory bowel diseases clinical trials · Gut · 2026 · Same journal
• Toward a CKLM framework for integrated clinical trial design · Gut · 2026 · Same journal
• Large language models for detecting colorectal polyps in endoscopic images—further research is required · Gut · 2026 · Same journal
• USP20 promotes CD8 + T cell exhaustion and impairs KRAS G12D inhibitor efficacy by orchestrating cholesterol metabolism and autophagy in pancreatic cancer · Gut · 2026 · Same journal
• Galectin-14, a primate-specific oncofetal protein, impairs anti-tumour immunity in hepatocellular carcinoma by driving elevated heparan sulphate modification · Gut · 2026 · Same journal
• Cancer neuroscience in cholangiocarcinoma: from perineural invasion to neuroimmune control · Gut · 2026 · Same journal
• Cryptogenic steatotic liver disease: a lean phenotype associated with increased liver-related mortality · Gut · 2026 · Same journal
• Safety and efficacy of extended surveillance intervals following colorectal endoscopic submucosal dissection: an international multicentre study · Gut · 2026 · Same journal